Drug Trial Radar · NCT00712140
Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer
Last checked: Nov 20, 2026Latest source record: Sep 2, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
4,000
Planned (sponsor's estimate)
Start
Oct 2007
Primary completion
Oct 2011
Sponsor
- Lead sponsor
- Warwick Medical SchoolAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 9, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known which regimen of trastuzumab is more effective in treating early breast cancer. PURPOSE: This randomized phase III trial is comparing two trastuzumab regimens to see how well they work in treating women with HER2-positive early breast cancer.
Conditions
- Breast Cancer
Interventions
trastuzumabBiological
Given IV
parenteral chemotherapyDrug
per the local institutional protocols either concurrently with or sequentially to trastuzumab
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free survival
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Addenbrooke's Hospital
Cambridge, England, United Kingdom · Recruiting
Cumberland Infirmary
Carlisle, England, United Kingdom · Recruiting
Derbyshire Royal Infirmary
Derby, England, United Kingdom · Recruiting
Eastbourne District General Hospital
Eastbourne, England, United Kingdom · Recruiting
Luton and Dunstable Hospital
Luton, England, United Kingdom · Recruiting
Clatterbridge Centre for Oncology
Merseyside, England, United Kingdom · Recruiting
James Cook University Hospital
Middlesbrough, England, United Kingdom · Recruiting
Mount Vernon Cancer Centre at Mount Vernon Hospital
Northwood, England, United Kingdom · Recruiting
Peterborough Hospitals Trust
Peterborough, England, United Kingdom · Recruiting
New Cross Hospital
Wolverhampton, England, United Kingdom · Recruiting
Aberdeen Royal Infirmary
Aberdeen, Scotland, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.